Printer Friendly

Articles from Chain Drug Review (December 7, 1998)

1-91 out of 91 article(s)
Title Author Type Words
A brief history of CVS. 2458
A look at Japan's pharmacies. Transcript 824
Adaptability one key to CVS' success. 681
Ahold taps Baird to head Giant. 280
AmeriSource profits up 23% before charges. 480
Barr Pursues Three-Part Business Strategy. 555
Bartell opens its 44th drug store. 131
Battle Over Warfarin Sodium Waged by Barr on Many Fronts. 845
Boots takes its brand of retailing worldwide. 936
Bristol-Myers realigns top execs to drive growth. 456
CACDS assesses industry in Canada. 492
Chain drug stocks. 225
Chain drug suppliers post single-digit gains. Industry Overview 1269
Chain turns in a record performance. 1056
Chain's expansion is far from over. Company Profile 977
Charting the Value of Medicines. 584
Combining the best of CVS, Arbor. 1082
Consolidation sweeps Detroit. 1113
Consulting Finn Advocates A Hard Look at Mergers. 367
Consumer Coalition Launches Campaign. 261
Corporate culture sets CVS apart. 542
CVS bolsters role of pharmacists. 995
CVS continues to reinvent itself. 676
CVS extends reach with Arbor buy. 1136
CVS fights for top Spot in Atlanta. 846
CVS finds perfect match in Arbor. 1308
CVS Health Connection passes test. 481
CVS hits stride after independence. 1056
CVS is in the process of creating a drug chain for the 21st century. 1251
CVS makes its mark in Cleveland. 933
CVS' new '220-store laboratory'. 1045
CVS-Revco deal reshapes industry. 962
Drug Town's Susich to retire after 28 years. 232
Explosive growth a CVS hallmark. 1476
Farmacias Ahumada thrives on innovation. 1179
Farmacias El Amal consolidates position in Puerto Rico. 805
FDA Approves New Study of Warner-Lambert's ReZulin. 219
Genovese buy makes Eckerd force in N.Y. Vogel, Mike 797
Genovese earnings soar in qtr. 418
Genovese: An advocate for the industry. 658
Getting the CVS message across. 1185
Goldstein: The chief architect of CVS. 718
Growth accelerates at Israel's Super-Pharm. 627
Henney to Speak. 174
Horizon results benefit from acquired outlets. 540
Implementing micromerchandising. 1030
Japanese get insights from NACDS. 1054
Jean Coutu enhances patient care, service. 844
Judge backs Rx makers in discriminatory pricing suit. 637
Latest CVS prototype built with convenience of customers in mind. 550
Lilly Ups Support for Evista. 145
London an industry pioneer. 703
Longs expands board of directors. 135
Longs net up 10% on 13% sales gain. 478
Major family-owned drug chains pass from the scene. Pinto, David 926
Making the Arbor integration work. 821
Matsumotokiyoshi grows despite climate. 534
Maybelline to kick off year with new products. 375
McKesson Debut. 191
McNeil, AphA Campaign Targets O-T-C Use. 378
MedPartners Plans to Focus On Managing Rx Benefits. 267
Megachains battle in Philadelphia. 323
Merck Unveils 'Get-to-Goal Guarantee'. 435
N.Y.C. a high priority for CVS. 915
NDMA Targets Supplements. 317
Neptune-Star stakes claim in China. 718
Neutrogena cosmetics to debut. 566
NWDA meeting tackles issue of privacy. 1082
Omni Selects RxAmerica To Handle Pharmacy Plan. 312
Other retailers. 183
PacifiCare Health Systems Tabs Hoops Chairman. CEO. 392
Parent companies & combo operators. 237
Patient Care or Marketing? Coopman, Robert 444
Pfizer Consumer Health Care Group promotes two execs. 134
Profits at Eckerd strengthen during third quarter. Company Profile 604
Program Tracks Generics Price Swings. 187
Rhone-Poulenc, Hoechst Merging Life Sciences Units. 250
Rite Aid ups ante in PBM business. 666
Rite Aid's PL program recognized. 174
Role of private label expands. 820
SDM doesn't rest on its laurels. 710
Sidmak Labs Succeeds in Getting Itself Back on Track. 533
Strict focus pays dividends for Benavides. 499
Super-Pharm of Israel marks 20th anniversary. 946
The 10 best drug chains outside the U.S. 627
The CVS store format. 117
Today's CVS is 'bigger, better'. 1279
Two FDA Actions Blur Lines Between Medicines, Food. 669
Walgreens names Karlin exec VP. 240
Wall Street analysts bullish on CVS. 1836
Zeneca's Nolvadex WINS FDA Okay. 154

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |